These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32507119)

  • 1. Impact of the COVID-19 pandemic on patients with pre-existing anxiety disorders attending secondary care.
    Plunkett R; Costello S; McGovern M; McDonald C; Hallahan B
    Ir J Psychol Med; 2021 Jun; 38(2):123-131. PubMed ID: 32507119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A longitudinal evaluation of the impact of the COVID-19 pandemic on patients with pre-existing anxiety disorders.
    Hennigan K; McGovern M; Plunkett R; Costello S; McDonald C; Hallahan B
    Ir J Psychol Med; 2021 Dec; 38(4):258-265. PubMed ID: 33818322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 2-year longitudinal evaluation of the impact of the COVID-19 pandemic on individuals with pre-existing anxiety disorders.
    McLoughlin A; Mulholland K; McMahon E; Plunkett R; Hennigan K; McDonald C; Hallahan B
    Ir J Psychol Med; 2023 Sep; 40(3):437-444. PubMed ID: 37051901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of COVID-19 on a cohort of patients treated with clozapine.
    Fahy Y; Dineen B; McDonald C; Hallahan B
    Ir J Psychol Med; 2021 Dec; 38(4):249-257. PubMed ID: 33818330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the COVID-19 pandemic on patients with pre-existing mood disorders.
    McLoughlin J; O'Grady MM; Hallahan B
    Ir J Psychol Med; 2022 Dec; 39(4):363-372. PubMed ID: 33910656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-year longitudinal evaluation of the impact of the COVID-19 pandemic on pre-existing mental health service attenders.
    O'Gorman E; Rainford A; Devaney E; O'Mahony B; McLoughlin J; Hallahan B
    Ir J Psychol Med; 2024 May; ():1-7. PubMed ID: 38818869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mental health symptoms 1 year after the COVID-19 outbreak in Spain: The role of pre-existing mental disorders and their type.
    Monistrol-Mula A; Felez-Nobrega M; Moneta MV; Condominas E; Vilagut G; Martin-Iñigo L; Domènech-Abella J; Sánchez-Niubó A; Mortier P; Cristóbal-Narváez P; Olaya B; Alonso J; Haro JM
    J Affect Disord; 2022 Dec; 318():22-28. PubMed ID: 36058361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Is the Impact of COVID-19 Pandemic on Patients with Pre-Existing Mood or Anxiety Disorder? An Observational Prospective Study.
    Tundo A; Betro' S; Necci R
    Medicina (Kaunas); 2021 Mar; 57(4):. PubMed ID: 33804912
    [No Abstract]   [Full Text] [Related]  

  • 9. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors.
    Mazza MG; De Lorenzo R; Conte C; Poletti S; Vai B; Bollettini I; Melloni EMT; Furlan R; Ciceri F; Rovere-Querini P; ; Benedetti F
    Brain Behav Immun; 2020 Oct; 89():594-600. PubMed ID: 32738287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts.
    Pan KY; Kok AAL; Eikelenboom M; Horsfall M; Jörg F; Luteijn RA; Rhebergen D; Oppen PV; Giltay EJ; Penninx BWJH
    Lancet Psychiatry; 2021 Feb; 8(2):121-129. PubMed ID: 33306975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the COVID-19 pandemic and psychiatric symptoms in people with preexisting obsessive-compulsive, eating, anxiety, and mood disorders: a systematic review and meta-analysis of before-after studies.
    van Reekum EA; Woo JJ; Petropoulos JA; Samaan Z; Mbuagbaw L
    Psychiatry Clin Neurosci; 2023 Nov; 77(11):583-591. PubMed ID: 37565691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the COVID-19 pandemic and lockdown restrictions on psychosocial and behavioural outcomes among Australian adults with type 2 diabetes: Findings from the PREDICT cohort study.
    Sacre JW; Holmes-Truscott E; Salim A; Anstey KJ; Drummond GR; Huxley RR; Magliano DJ; van Wijngaarden P; Zimmet PZ; Speight J; Shaw JE
    Diabet Med; 2021 Sep; 38(9):e14611. PubMed ID: 34053106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing the COVID-19 pandemic in people with mental disorders: An exploratory telephone interview study in a psychiatric outpatient department.
    Kertzscher L; Kohls E; Baldofski S; Moeller R; Schomerus G; Rummel-Kluge C
    Compr Psychiatry; 2022 Jul; 116():152313. PubMed ID: 35429763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis.
    Chiaravalloti ND; Amato MP; Brichetto G; Chataway J; Dalgas U; DeLuca J; Meza C; Moore NB; Feys P; Filippi M; Freeman J; Inglese M; Motl R; Rocca MA; Sandroff BM; Salter A; Cutter G; Feinstein A;
    J Neurol; 2021 May; 268(5):1598-1607. PubMed ID: 32813051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal evaluation of the impact of the COVID-19 pandemic on a cohort of patients treated with clozapine.
    Rainford A; Moran S; McMahon E; Fahy YP; McDonald C; Hallahan B
    Ir J Psychol Med; 2023 Sep; 40(3):396-401. PubMed ID: 35156601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Pandemic and Mental Health: Prevalence and Correlates of New-Onset Obsessive-Compulsive Symptoms in a Canadian Province.
    Abba-Aji A; Li D; Hrabok M; Shalaby R; Gusnowski A; Vuong W; Surood S; Nkire N; Li XM; Greenshaw AJ; Agyapong VIO
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32987764
    [No Abstract]   [Full Text] [Related]  

  • 17. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.
    COVID-19 Mental Disorders Collaborators
    Lancet; 2021 Nov; 398(10312):1700-1712. PubMed ID: 34634250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in humor and sarcasm use based on anxiety and depression symptom severity during the COVID-19 pandemic.
    Rothermich K; Ogunlana A; Jaworska N
    J Psychiatr Res; 2021 Aug; 140():95-100. PubMed ID: 34102518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and changes in boredom, anxiety and well-being among Ghanaians during the COVID-19 pandemic: a population-based study.
    Boateng GO; Doku DT; Enyan NIE; Owusu SA; Aboh IK; Kodom RV; Ekumah B; Quansah R; Boamah SA; Obiri-Yeboah D; Nsabimana E; Jansen S; Armah FA
    BMC Public Health; 2021 May; 21(1):985. PubMed ID: 34039313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding health anxiety in the COVID-19 pandemic.
    Heinen A; Varghese S; Krayem A; Molodynski A
    Int J Soc Psychiatry; 2022 Dec; 68(8):1756-1763. PubMed ID: 34823387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.